Time to reset economy

Get App

Time to reset economy

you are here: HomeNewsBusiness
Last Updated : Jul 16, 2018 12:38 PM IST | Source: PTI

Suven Life gets patents from Europe, South Korea

"We are pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally," Suven Life CEO Venkat Jasti said.

Representative Image
Representative Image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Suven Life Sciences today said it has been granted a product patent by Europe and South Korea each for a new chemical entity (NCE) used in treatment of disorders associated with neurodegenerative diseases.

These patents are valid through 2033 and 2034, respectively, the company said in a BSE filing.

"We are pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally," Suven Life CEO Venkat Jasti said.

Close

The granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson's and schizophrenia, it added.

Shares of Suven Life Sciences were trading 0.55 per cent down at Rs 216.05 on BSE.

Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Jul 16, 2018 12:32 pm
Sections
Follow us on